[DOI] [PMC free article] [PubMed] [Google Scholar] 237.Franceschini D, Paroli M, Francavilla V, Videtta M, Morrone S, Labbadia G, Cerino A, Mondelli MU, Barnaba V
Bioorg Med Chem Lett 23(11):33253328 Hamdy A, Sayed RH, El-Yamany MF, Helal GK, Fahmy MI
Source: #Pharma #GlobalExpansion #GLP1 #Obesity #Diabetes #Hanmi #StrategicPartnership Hanmi Pharmaceuticals Partners with Laboratorios Sanfer for Mexico GLP-1 Obesity Therapy Hanmi Pharmaceuticals has signed an exclusive distribution agreement with Mexicos Laboratorios Sanfer to bring its #GLP-1 #obesity therapy #efpeglenatide, the first #domestically developed GLP-1 class treatment from Korea, to the #Mexican market, alongside its #Dapalon #diabetes portfolio
Injection therapy typically produces 5-10% additional weight loss compared to oral formulations when used at equivalent doses
If eligible, your Ro-affiliated provider will write a prescription for the appropriate GLP-1 treatment
Semaglutide Maintenance Program Since our medical weight loss program on semaglutide includes health coaching, we are confident that you would have all the help you need from us to make the diet and lifestyle changes that you seek
